<DOC>
	<DOCNO>NCT02351414</DOCNO>
	<brief_summary>MPO conduct PMCF study evaluate safety efficacy EVOLUTION® Total Knee Arthroplasty ( TKA ) component market EU . These type study require regulatory authority device medium long-term clinical evidence available time gain approval market EU . This study design accordance MEDDEV 2.12/2 rev 2 .</brief_summary>
	<brief_title>Post Market Follow-Up Study EVOLUTION® Total Knee Arthroplasty System With Cruciate Sacrificing Inserts</brief_title>
	<detailed_description>MicroPort Orthopedics Inc. ( MPO ) currently market EVOLUTION® TKA System globally , include European Union ( EU ) . As part process gain approval market EU , MicroPort conduct post market clinical follow-up ( PMCF ) study evaluate safety efficacy system . These type study require regulatory authority TKA device medium long-term clinical evidence available time gain approval market EU . The objective study evaluate component survivorship , cumulative revision rate , functional outcome score , subject satisfaction early , midterm , long-term follow-up .</detailed_description>
	<mesh_term>Joint Diseases</mesh_term>
	<criteria>To include study , subject must meet following criterion : Has previously undergone primary TKA following : noninflammatory degenerative joint disease include osteoarthritis , traumatic arthritis , avascular necrosis ; inflammatory degenerative joint disease include rheumatoid arthritis correction functional deformity . Subject implant specified combination component Subject willing able complete require study visit assessment Subject plan available 10 year postoperative followup visit Subject willing sign approve Informed Consent document Subject must least 2 year post TKA prior inform consent . Previously implanted bilateral subject TKAs enrol study provide : 1 ) specify combination component implant , 2 ) aspect Inclusion/Exclusion Criteria satisfy , 3 ) enrollment exceed subject count specify Clinical Trial Agreement , 4 ) subject agree second Informed Consent document specific second TKA . Prospective enrollment previously unimplanted knee permit study . Subjects exclude meet follow criterion : Subject skeletally immature ( less 21 year age ) time implantation Subject currently enrol another clinical investigation Subject unwilling unable sign Informed Consent document Subject document substance abuse issue Subject emotional neurological condition would preempt ability willingness participate study Subject body mass index ( BMI ) great 40 Subject currently incarcerate impend incarceration</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Ankylosis</keyword>
	<keyword>Revision procedure</keyword>
	<keyword>Correction functional deformity</keyword>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>Arthritis</keyword>
</DOC>